Presence of Variations in Ribosomal Protein L16 Corresponding to Susceptibility of Enterococci to Oligosaccharides (Avilamycin and Evernimicin)
- 1 December 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (12) , 3425-3427
Abstract
Fragments (414 bp) of the gene-encoding ribosomal protein L16 from Enterococcus faecium and Enterococcus faecalis that were resistant and susceptible to the oligosaccharide antibiotics avilamycin and evernimicin (SCH 27899) were sequenced and compared. The susceptible E. faecalis and E. faecium isolates had sequences that were similar to those of the type strains. All resistant E. faecalis isolates contained the same base pair variation [CGT (Arg-56) → CAT (His-56)]. The same variation and two additional variations [ATC (Ile-52) → ACC (Thr-52) and ATC (Ile-52) → AGC (Ser-52)] were found in the resistant E. faecium isolates. This study indicated that resistance to the oligosaccharides in enterococci is associated with variations in the ribosomal protein L16.Keywords
This publication has 16 references indexed in Scilit:
- Association Between the Use of Avilamycin for Growth Promotion and the Occurrence of Resistance among Enterococcus faecium from Broilers: Epidemiological Study and Changes Over TimeMicrobial Drug Resistance, 2000
- Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compoundsDiagnostic Microbiology and Infectious Disease, 1999
- Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelinesDiagnostic Microbiology and Infectious Disease, 1999
- Association Between Decreased Susceptibility to a New Antibiotic for Treatment of Human Diseases, Everninomicin (SCH 27899), and Resistance to an Antibiotic Used for Growth Promotion in Animals, AvilamycinMicrobial Drug Resistance, 1998
- Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in DenmarkAPMIS, 1998
- Comparative in-vitro activity of SCH 27899, a novel eveminomicin, and vancomycinJournal of Antimicrobial Chemotherapy, 1996
- Multidrug-Resistant Enterococcus faeciumDrugs, 1994
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- Avilamycin, an inhibitor of the 30 S ribosomal subunits functionFEBS Letters, 1973